Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1996-06-07
1998-11-17
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241351, 4241341, 4242771, 4241841, 4241921, 512 12, 5303873, A61K 39365, A61K 3900, A61K 3800, C12P 2108
Patent
active
058372431
ABSTRACT:
Multispecific multivalent molecules which are specific to an Fc receptor (FcR), and therapeutic uses and therapeutic uses and methods for making the molecules are described.
REFERENCES:
Jung, Gundram, et al., (1991), "Target Cell-Induced T cell Activation with Bi-and Trispecific Antibody Fragments", Eur. J. Immunol., vol. 21, pp. 2431-2435.
Fanger, M. et al. (1994) "Production and Use of Anti-FcR Bispecific Antibodies" Immunomethods 4 (1): 72-81.
Repp, R. et al. (1994) "G-CSF Stimulated Neutrophils as Effector Cells In Immunotherapy With a Bispecific Antibody to FcgammaRI and to HER-2
eu (MDX210): Preclinicla Studies", Immunobiology, 191 (2-3): 250-25.
Mabondzo, A. et al. (1994) "Antibody-Dependent Cellular Cytotoxicity and Neutralization of Human Immunodeficiency Virus Type 1 By High Affinity Cross-Linking of gp41 to Human Macrophage Fc IgG Receptor Using Bispecific Antibody" Journal of General Virology, 75 (6): 1451-1456.
Chen, J. et al. (1995) "An Immunoconjugate of Lys3-Bombesin and Monoclonal Antibody 22 Can Specifically INduce FcgammaRI (CD64)-Dependent Monocyte-and Neutrophil-Mediated Lysis of Small Cell Carcinoma of the Lung Cells" Clinical Cancer Research, 1(4); 425-434.
Graziano, R. et al. (1995) "Construction and Characterization of a Humanized Anti-Gamma-lg Receptor Type I (Fcgamma RI) Monoclonal Antibody" The Journal of Immunology, 155 (10): 4996-5002.
Jawetz et al. Medical Microbiology 19th Edition 1991 p. 115 Immunology.
Deo Yashwant M.
Goldstein Joel
Graziano Robert
Somasundaram Chezian
Bansal Geetha
Feisee Lila
Medarex Inc.
LandOfFree
Therapeutic compounds comprised of anti-Fc receptor antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds comprised of anti-Fc receptor antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds comprised of anti-Fc receptor antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-881394